Longitudinal Study of Primary Osteoporosis in Shanghai Postmenopausal Women

Shanghai University of Traditional Chinese Medicine3,000 enrolled

Overview

To popularize knowledge of prevention and health care of osteoporosis.To investigate the prevalence of primary osteoporosis in community residents.

1. Objective: * To popularize knowledge of prevention and health care of osteoporosis. * To investigate the prevalence of primary osteoporosis in community residents. 2. Method: * The survey study included the five boroughs of six communities in Shanghai (Xuhui District 2, Pudong New Area 1, Minhang District 1, Pudong New Area 1, Jiading District 1). 10,000 participants are expected to be included. * Through a questionnaire and physical examination form, carries on the investigation to the 50-85 years old postmenopausal women during the 3-year follow-up period. * Make a survey of Bone Mineral Density,SF-36,international osteoporosis foundation ONE-MINUTE OSTEOPOROSIS RISK TEST,Markers of bone metabolism test,EQ-5D,Hepatic-renal function test and thyroid stimulating hormone level test. * Physicians in each community as the backbone, Shanghai University of Traditional Chinese Medicine, Longhua Hospital is responsible for personnel training. * Shanghai Clinical Research Center is responsible for program and data management. * Shanghai District Health and Family Planning Commission is responsible for coordinating the organization.

Study Type

OBSERVATIONAL

Enrollment

3,000

Conditions

Primary Osteoporosis

Eligibility

Sex: FEMALEMin age: 50 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Had clinical diagnosis of osteoporosis. * With Bone Mineral Density by dual energy X-ray examination, T value \<-2.5 or less. * Be willing to and be able to join in the study and signed Informed consent. Exclusion Criteria: * Excluding the impact of endocrine diseases of bone metabolism (gonadal, adrenal, parathyroid and thyroid disease), rheumatoid arthritis and other autoimmune diseases that affect the absorption of calcium and vitamin D and regulation of the digestive tract and kidney disease, multiple myeloma and other malignant diseases, long-term use of corticosteroids or other drugs affecting bone metabolism, and a variety of congenital and acquired diseases of bone metabolism. * if they were unable to complete the study survey.

Locations (1)

Longhua Hospital

Shanghai, Shanghai Municipality, China

Outcomes

Primary Outcomes

Bone Mineral Density

Time frame: baseline

Secondary Outcomes

SF-36

a composite of functional status

Time frame: baseline

international osteoporosis foundation ONE-MINUTE OSTEOPOROSIS RISK TEST

Time frame: baseline

Markers of bone metabolism test

Fasting peripheral blood collected 2ml.Markers of bone metabolism test，including alkaline phosphatase, 25-hydroxy-vitamin D，prepeptide typeⅠ procollagen，osteocalcin，type I collagen cross-linked C-terminal telopeptide，tartrate resistant acid phosphatase.

Time frame: baseline

EQ-5D

A standardised instrument for use as a measure of health outcome.

Time frame: baseline

Hepatic-renal function test

Fasting peripheral blood collected 2ml.Hepatic-renal function test，including calcium, phosphorus, creatinine.

Time frame: baseline

thyroid stimulating hormone level test

Fasting peripheral blood collected 1ml for thyroid stimulating hormone test.

Time frame: baseline

Central Contacts

Xuejun Cui, Dr.

CONTACT

13917715524@139.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.